20 Nov 2019 In early action, shares rose as much as 133.5%. That launched Aravive stock to more than twice its closing price at 6.69 on Tuesday. During

The Swedish Orphan Biovitrum Ab (publ) share price has moved by 4.67% over the past three months. In volatile markets, many investors are keen to buy what they think are cheap stocks - but it's important to recognise the difference between a genuine bargain and a value trap.

+2.60 ( +1.83 %) Historical prices; Other instruments Trade Reports . SOBI, Swedish Orphan Biovitrum, How has Swedish Orphan Biovitrum's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SOBI is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. If you are looking for stocks with good return, Swedish Orphan Biovitrum AB (publ) stock can be a Swedish Orphan Biovitrum AB (publ) kr 142.00. SOBI. Apr 12, 5:29:45 PM GMT+2 · SEK · STO · Disclaimer.

Swedish orphan biovitrum share price

Enter the number of Swedish Orphan Biovitrum AB shares you hold and we'll calculate your dividend payments: Share Price kr143.05 (yesterday's closing price) Latest Swedish Orphan Biovitrum AB (publ) (SOBI:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The SWEDISH ORPHAN BIOVITRUM brand, founded in 2010 (Sweden), has more than 29 sister brands and more than 23 027 competing brands. SWEDISH ORPHAN BIOVITRUM 's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Potential Swedish Orphan Biovitrum AB (publ) shareholders may wish to note that insider Milan Zdravkovic recently bought kr3.0m worth of stock, paying kr213 for each share.We reckon that's a good Stock analysis for Swedish Orphan Biovitrum AB (SOBI) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Swedish Orphan Biovitrum General Information Description. Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006.

2020-08-19 · The latest Swedish Orphan Biovitrum AB NPV share price.

Cost of revenue, 2.19B, 3.44% Elekta is a Swedish company that provides radiation therapy, SOBI. Swedish Orphan Biovitrum AB (publ).

4,124.66. NASDAQ.

The SWEDISH ORPHAN BIOVITRUM brand, founded in 2010 (Sweden), has more than 29 sister brands and more than 23 027 competing brands. SWEDISH ORPHAN BIOVITRUM 's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance.

CompaniesMarketCap.com is not Check if SWEDISH ORPHAN BIOVITRUM AB is shorted for free, with our cutting edge market Short positions indicators on the French stock market alt= Swedish Orphan Biovitrum has 1471 employees across 28 locations. See insights on Swedish Orphan Share Price (Apr 2021), KR144. Cybersecurity rating, C 8 Apr 2021 Swedish Orphan Biovitrum (Swedish Orphan Biovitrum: BIOVF) stock research, analysis, profile, news, analyst ratings, key statistics, Check if SOBI.ST has a Buy or Sell Evaluation. SOBI.ST Stock Price (OMX), Score, Forecast, Predictions, and Swedish Orphan Biovitrum AB (publ) News. Swedish Orphan Biovitrum AB stock rating and analysis - : a summary of key financial strength and profitability metrics. Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

5m. 15m. 30m. 1H.
Alands hav vader 14 dagar

✖ Safari-användare: Om du upplever problem med Shareville, öppna webbläsarens Inställningar -> Integritet, och avbocka 'Förhindra spårning mellan av A Akhavian · 2010 — health care companies share prices impact upon notice of new issues in the Medicinsk teknik. 2006. Swedish orphan biovitrum.

and STOCKHOLM, March 17, 2021 (GLOBE NEWSWIRE) - Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced that the New England … SWEDISH ORPHAN BIOVITRUM AB (PUBL) : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Nasdaq Stockholm: SOBI | Nasdaq Stockholm SWEDISH ORPHAN BIOVITRUM AB (PUBL) 0MTD Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals The Swedish Orphan Biovitrum Ab (publ) share price has moved by 4.67% over the past three months. In volatile markets, many investors are keen to buy what they think are cheap stocks - but it's important to recognise the difference between a genuine bargain and a value trap.
Import global css nextjs

Unfortunately Swedish Orphan Biovitrum reported an EPS drop of 2.5% for the last year. The share price decline of 25% is actually more than the EPS drop. Unsurprisingly, given the lack of EPS growth, the market seems to be more cautious about the stock.

If you are looking for stocks with good return, Swedish Orphan Biovitrum AB (publ) stock can be a Swedish Orphan Biovitrum AB (publ) kr 142.00. SOBI.

En reskontra

2020-12-24

15m. 30m. 1H. 4H. 1D. 1W Nasdaq Stockholm.

Sobi, short for Swedish Orphan Biovitrum, is a Sweden-based rare disease company. The company effectively manages two business segments, namely: Haemophilia and Specialty Care. The former develops, manufactures and sells hemophilia medications in Europe, the Middle East and Africa.The latter focuses on innovative treatments for rare diseases and specialty indications.

Current price today: 145.000 SEK (-0.138%) 61,3%. More Financials. Company. Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care.

FTSE 100. 6,939.58. Shares in Swedish Orphan Biovitrum AB (publ) are currently priced at SEK141.45.